Get the Stockscreener App
1.6477
2.68%
-0.0323
Medicinova Inc stock is traded at $1.6477, with a volume of 6,217.
It is down -2.68% in the last 24 hours and down -17.42% over the past month.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.68
Open:
$1.63
24h Volume:
6,217
Relative Volume:
0.16
Market Cap:
$82.40M
Revenue:
-
Net Income/Loss:
$-9.51M
P/E Ratio:
-6.5908
EPS:
-0.25
Net Cash Flow:
$-10.96M
1W Performance:
-6.57%
1M Performance:
-17.42%
6M Performance:
+24.81%
1Y Performance:
-13.95%
1-Day Range:
$1.60
$1.68
1-Week Range:
$1.60
$1.8495
52-Week Range:
$1.12
$2.16
Medicinova Inc Stock (MNOV) Company Profile
Name
Medicinova Inc
Sector
Industry
Phone
858-373-1500
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-21 | Initiated | Maxim Group | Buy |
| Mar-25-19 | Resumed | B. Riley FBR | Buy |
| Mar-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-18-17 | Initiated | Credit Suisse | Outperform |
| Jan-04-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-24-12 | Downgrade | MLV & Co | Buy → Hold |
| Oct-18-11 | Reiterated | MLV Capital | Buy |
| Jun-22-11 | Initiated | Global Hunter Securities | Buy |
| May-12-10 | Initiated | Wedbush | Outperform |
| Nov-12-08 | Reiterated | Ladenburg Thalmann | Buy |
| May-15-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jul-09-07 | Initiated | Punk, Ziegel & Co | Buy |
View All
Medicinova Inc Stock (MNOV) Latest News
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat
MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
MediciNova Announces Update of Phase 2/3 Clinical Trial of - GlobeNewswire
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) - StockTitan
MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com - Defense World
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
MediciNova, Inc. (NASDAQ:MNOV) Shares Sold by Dimensional Fund Advisors LP - Defense World
MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago - Yahoo Finance
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS - Smartkarma
MNOVMedicinova, Inc. Latest Stock News & Market Updates - StockTitan
Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Rises By 19.3% - MarketBeat
MediciNova to Support NIH-Funded Expanded Access Clinical - GlobeNewswire
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) - StockTitan
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average of $1.42 - MarketBeat
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Insigneo Advisory Services LLC Has $6.10 Million Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World
Intech Investment Management LLC Takes Position in MSA Safety Incorporated (NYSE:MSA) - MarketBeat
Minerals Technologies (NYSE:MTX) Upgraded at StockNews.com - MarketBeat
Monroe Capital (NASDAQ:MRCC) Stock Crosses Above 200 Day Moving Average of $7.49 - MarketBeat
MARXU stock soars to all-time high of $12.15 amid market optimism - Investing.com Australia
Marcus (NYSE:MCS) Upgraded by StockNews.com to Hold - Defense World
Mistras Group senior EVP sells over $349k in company stock - Investing.com
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX) - Stockhouse Publishing
Summit Trail Advisors LLC Buys 403 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World
MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - Longview News-Journal
MasterBrand (NYSE:MBC) Hits New 52-Week High at $19.10 - MarketBeat
ProShare Advisors LLC Sells 43,073 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mutual of America Capital Management LLC Decreases Stake in MSA Safety Incorporated (NYSE:MSA) - Defense World
2024-09-23 | Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More | NDAQ:MGNX | Press Release - Stockhouse Publishing
King Luther Capital Management Corp Buys 13,051 Shares of Mercury Systems, Inc. (NASDAQ:MRCY) - Defense World
Hagens Berman Reminds MacroGenics (MGNX) Investors of the - GlobeNewswire
Legacy Financial Advisors Inc. Grows Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World
XTX Topco Ltd Purchases 1,054 Shares of Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World
Edgestream Partners L.P. Invests $1.67 Million in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Down 13% in 1 Day, Is Moderna Stock in Trouble? - The Motley Fool
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat
Traders Purchase High Volume of Moderna Put Options (NASDAQ:MRNA) - Defense World
Clear Street LLC Acquires 1,335 Shares of Metal Sky Star Acquisition Co. (NASDAQ:MSSA) - Defense World
MGNX Stockholders Have Opportunity to Lead MacroGenics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
MacroGenics (NASDAQ:MGNX) Lifted to “Strong-Buy” at Evercore ISI - Defense World
Hagens Berman Reminds MacroGenics (MGNX) Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of Sept. 24, 2024 - ForexTV.com
The Gross Law Firm Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MGNX - EIN News
Parallel Advisors LLC Reduces Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Barclays Lowers Mplx (NYSE:MPLX) Price Target to $45.00 - Defense World
Comparing Prestige Consumer Healthcare (NYSE:PBH) and MediciNova (NASDAQ:MNOV) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc.MGNX - Longview News-Journal
Bank of New York Mellon Corp Purchases 324 Shares of MakeMyTrip Limited (NASDAQ:MMYT) - Defense World
Medicinova Inc Stock (MNOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):